Concentration of Antifungal Agents within Host Cell Membranes: a New Paradigm Governing the Efficacy of Prophylaxis

Posaconazole prophylaxis has proven highly effective in preventing invasive fungal infections, despite relatively low serum concentrations. However, high tissue levels of this agent have been reported in treated patients. We therefore hypothesized that the intracellular levels of antifungal agents a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Antimicrobial Agents and Chemotherapy 2011-12, Vol.55 (12), p.5732-5739
Hauptverfasser: Campoli, P, Al Abdallah, Q, Robitaille, R, Solis, N. V, Fielhaber, J. A, Kristof, A. S, Laverdiere, M, Filler, S. G, Sheppard, D. C
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 5739
container_issue 12
container_start_page 5732
container_title Antimicrobial Agents and Chemotherapy
container_volume 55
creator Campoli, P
Al Abdallah, Q
Robitaille, R
Solis, N. V
Fielhaber, J. A
Kristof, A. S
Laverdiere, M
Filler, S. G
Sheppard, D. C
description Posaconazole prophylaxis has proven highly effective in preventing invasive fungal infections, despite relatively low serum concentrations. However, high tissue levels of this agent have been reported in treated patients. We therefore hypothesized that the intracellular levels of antifungal agents are an important factor in determining the success of fungal prophylaxis. To examine the effect of host cell-associated antifungals on the growth of medically important molds, we exposed cells to antifungal agents and removed the extracellular drug prior to infection. Epithelial cells loaded with posaconazole and its parent molecule itraconazole, but not other antifungals, were able to inhibit fungal growth for at least 48 h and were protected from damage caused by infection. Cell-associated posaconazole levels were 40- to 50-fold higher than extracellular levels, and the drug was predominantly detected in cellular membranes. Fungistatic levels of posaconazole persisted within epithelial cells for up to 48 h. Therefore, the concentration of posaconazole in mammalian host cell membranes mediates its efficacy in prophylactic regimens and likely explains the observed discrepancy between serum antifungal levels and efficacy.
doi_str_mv 10.1128/AAC.00637-11
format Article
fullrecord <record><control><sourceid>pubmed_fao_a</sourceid><recordid>TN_cdi_pubmed_primary_21930891</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>21930891</sourcerecordid><originalsourceid>FETCH-LOGICAL-a498t-836ddcf06599159f1a6566639bf0fd87fc27349ba397ca7340f72653c733f8773</originalsourceid><addsrcrecordid>eNp1kk1vEzEQhi0EoiFw4wwWEgcktvhj7V1zQIqi0iIVqAQ9WxPH3nW1sSN705B_j8OWAgdO9ngevzPz2gg9p-SUUta-WyyWp4RI3lSUPkAzSlRbSaHkQzQrx7KqW1KfoCc535ASC0UeoxNGFSetojOUlzEYG8YEo48BR4cXYfRuFzoY8KIrmYz3fux9wBcxj3hphwF_tptVgmDzewz4i93jK0iw9t0Gn8dbm4IPHR57i8-c8wbM4Sh7leK2Pwzww-en6JGDIdtnd-scXX88-768qC6_nn9aLi4rqFU7Vi2X67Vxx54VFcpRkEJKydXKEbduG2dYw2u1Aq4aA2VLXMOk4Kbh3LVNw-fow6S73a02dj2NOeht8htIBx3B638zwfe6i7eaM86aUmmO3k4CJsWck3X3dynRR_N1MV__Mr-EBX8z4ZA3TN_EXQplvP-xL_7u7V7498sU4PUdANnA4Irfxuc_nGCC1-zY46uJ633X732yulTXAEYLoSnToinTzNHLCXIQNXSpCF1_Y4QKcvwTdS35T4Z6rlo</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Concentration of Antifungal Agents within Host Cell Membranes: a New Paradigm Governing the Efficacy of Prophylaxis</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Campoli, P ; Al Abdallah, Q ; Robitaille, R ; Solis, N. V ; Fielhaber, J. A ; Kristof, A. S ; Laverdiere, M ; Filler, S. G ; Sheppard, D. C</creator><creatorcontrib>Campoli, P ; Al Abdallah, Q ; Robitaille, R ; Solis, N. V ; Fielhaber, J. A ; Kristof, A. S ; Laverdiere, M ; Filler, S. G ; Sheppard, D. C</creatorcontrib><description>Posaconazole prophylaxis has proven highly effective in preventing invasive fungal infections, despite relatively low serum concentrations. However, high tissue levels of this agent have been reported in treated patients. We therefore hypothesized that the intracellular levels of antifungal agents are an important factor in determining the success of fungal prophylaxis. To examine the effect of host cell-associated antifungals on the growth of medically important molds, we exposed cells to antifungal agents and removed the extracellular drug prior to infection. Epithelial cells loaded with posaconazole and its parent molecule itraconazole, but not other antifungals, were able to inhibit fungal growth for at least 48 h and were protected from damage caused by infection. Cell-associated posaconazole levels were 40- to 50-fold higher than extracellular levels, and the drug was predominantly detected in cellular membranes. Fungistatic levels of posaconazole persisted within epithelial cells for up to 48 h. Therefore, the concentration of posaconazole in mammalian host cell membranes mediates its efficacy in prophylactic regimens and likely explains the observed discrepancy between serum antifungal levels and efficacy.</description><identifier>ISSN: 0066-4804</identifier><identifier>EISSN: 1098-6596</identifier><identifier>DOI: 10.1128/AAC.00637-11</identifier><identifier>PMID: 21930891</identifier><identifier>CODEN: AACHAX</identifier><language>eng</language><publisher>Washington, DC: American Society for Microbiology</publisher><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents ; Antifungal Agents ; Antifungal Agents - pharmacokinetics ; Antifungal Agents - pharmacology ; Aspergillus fumigatus ; Aspergillus fumigatus - drug effects ; Aspergillus fumigatus - growth &amp; development ; Biological and medical sciences ; blood serum ; Cell Line ; Cell Membrane ; Cell Membrane - metabolism ; cell membranes ; Chemoprevention ; disease control ; Epithelial Cells ; Epithelial Cells - metabolism ; Epithelial Cells - microbiology ; fungi ; host-pathogen relationships ; Humans ; itraconazole ; Itraconazole - pharmacokinetics ; Itraconazole - pharmacology ; Lung - cytology ; Macrophages ; Macrophages - metabolism ; Macrophages - microbiology ; mammals ; Medical sciences ; microbial growth ; Mycoses ; Mycoses - prevention &amp; control ; patients ; Pharmacology ; Pharmacology. Drug treatments ; Triazoles ; Triazoles - pharmacokinetics ; Triazoles - pharmacology</subject><ispartof>Antimicrobial Agents and Chemotherapy, 2011-12, Vol.55 (12), p.5732-5739</ispartof><rights>2015 INIST-CNRS</rights><rights>Copyright © 2011, American Society for Microbiology. All Rights Reserved.</rights><rights>Copyright © 2011, American Society for Microbiology. All Rights Reserved. 2011 American Society for Microbiology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a498t-836ddcf06599159f1a6566639bf0fd87fc27349ba397ca7340f72653c733f8773</citedby><cites>FETCH-LOGICAL-a498t-836ddcf06599159f1a6566639bf0fd87fc27349ba397ca7340f72653c733f8773</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3232766/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3232766/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=25253426$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21930891$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Campoli, P</creatorcontrib><creatorcontrib>Al Abdallah, Q</creatorcontrib><creatorcontrib>Robitaille, R</creatorcontrib><creatorcontrib>Solis, N. V</creatorcontrib><creatorcontrib>Fielhaber, J. A</creatorcontrib><creatorcontrib>Kristof, A. S</creatorcontrib><creatorcontrib>Laverdiere, M</creatorcontrib><creatorcontrib>Filler, S. G</creatorcontrib><creatorcontrib>Sheppard, D. C</creatorcontrib><title>Concentration of Antifungal Agents within Host Cell Membranes: a New Paradigm Governing the Efficacy of Prophylaxis</title><title>Antimicrobial Agents and Chemotherapy</title><addtitle>Antimicrob Agents Chemother</addtitle><addtitle>Antimicrob Agents Chemother</addtitle><description>Posaconazole prophylaxis has proven highly effective in preventing invasive fungal infections, despite relatively low serum concentrations. However, high tissue levels of this agent have been reported in treated patients. We therefore hypothesized that the intracellular levels of antifungal agents are an important factor in determining the success of fungal prophylaxis. To examine the effect of host cell-associated antifungals on the growth of medically important molds, we exposed cells to antifungal agents and removed the extracellular drug prior to infection. Epithelial cells loaded with posaconazole and its parent molecule itraconazole, but not other antifungals, were able to inhibit fungal growth for at least 48 h and were protected from damage caused by infection. Cell-associated posaconazole levels were 40- to 50-fold higher than extracellular levels, and the drug was predominantly detected in cellular membranes. Fungistatic levels of posaconazole persisted within epithelial cells for up to 48 h. Therefore, the concentration of posaconazole in mammalian host cell membranes mediates its efficacy in prophylactic regimens and likely explains the observed discrepancy between serum antifungal levels and efficacy.</description><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Antifungal Agents</subject><subject>Antifungal Agents - pharmacokinetics</subject><subject>Antifungal Agents - pharmacology</subject><subject>Aspergillus fumigatus</subject><subject>Aspergillus fumigatus - drug effects</subject><subject>Aspergillus fumigatus - growth &amp; development</subject><subject>Biological and medical sciences</subject><subject>blood serum</subject><subject>Cell Line</subject><subject>Cell Membrane</subject><subject>Cell Membrane - metabolism</subject><subject>cell membranes</subject><subject>Chemoprevention</subject><subject>disease control</subject><subject>Epithelial Cells</subject><subject>Epithelial Cells - metabolism</subject><subject>Epithelial Cells - microbiology</subject><subject>fungi</subject><subject>host-pathogen relationships</subject><subject>Humans</subject><subject>itraconazole</subject><subject>Itraconazole - pharmacokinetics</subject><subject>Itraconazole - pharmacology</subject><subject>Lung - cytology</subject><subject>Macrophages</subject><subject>Macrophages - metabolism</subject><subject>Macrophages - microbiology</subject><subject>mammals</subject><subject>Medical sciences</subject><subject>microbial growth</subject><subject>Mycoses</subject><subject>Mycoses - prevention &amp; control</subject><subject>patients</subject><subject>Pharmacology</subject><subject>Pharmacology. Drug treatments</subject><subject>Triazoles</subject><subject>Triazoles - pharmacokinetics</subject><subject>Triazoles - pharmacology</subject><issn>0066-4804</issn><issn>1098-6596</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kk1vEzEQhi0EoiFw4wwWEgcktvhj7V1zQIqi0iIVqAQ9WxPH3nW1sSN705B_j8OWAgdO9ngevzPz2gg9p-SUUta-WyyWp4RI3lSUPkAzSlRbSaHkQzQrx7KqW1KfoCc535ASC0UeoxNGFSetojOUlzEYG8YEo48BR4cXYfRuFzoY8KIrmYz3fux9wBcxj3hphwF_tptVgmDzewz4i93jK0iw9t0Gn8dbm4IPHR57i8-c8wbM4Sh7leK2Pwzww-en6JGDIdtnd-scXX88-768qC6_nn9aLi4rqFU7Vi2X67Vxx54VFcpRkEJKydXKEbduG2dYw2u1Aq4aA2VLXMOk4Kbh3LVNw-fow6S73a02dj2NOeht8htIBx3B638zwfe6i7eaM86aUmmO3k4CJsWck3X3dynRR_N1MV__Mr-EBX8z4ZA3TN_EXQplvP-xL_7u7V7498sU4PUdANnA4Irfxuc_nGCC1-zY46uJ633X732yulTXAEYLoSnToinTzNHLCXIQNXSpCF1_Y4QKcvwTdS35T4Z6rlo</recordid><startdate>20111201</startdate><enddate>20111201</enddate><creator>Campoli, P</creator><creator>Al Abdallah, Q</creator><creator>Robitaille, R</creator><creator>Solis, N. V</creator><creator>Fielhaber, J. A</creator><creator>Kristof, A. S</creator><creator>Laverdiere, M</creator><creator>Filler, S. G</creator><creator>Sheppard, D. C</creator><general>American Society for Microbiology</general><scope>FBQ</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>20111201</creationdate><title>Concentration of Antifungal Agents within Host Cell Membranes: a New Paradigm Governing the Efficacy of Prophylaxis</title><author>Campoli, P ; Al Abdallah, Q ; Robitaille, R ; Solis, N. V ; Fielhaber, J. A ; Kristof, A. S ; Laverdiere, M ; Filler, S. G ; Sheppard, D. C</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a498t-836ddcf06599159f1a6566639bf0fd87fc27349ba397ca7340f72653c733f8773</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Antifungal Agents</topic><topic>Antifungal Agents - pharmacokinetics</topic><topic>Antifungal Agents - pharmacology</topic><topic>Aspergillus fumigatus</topic><topic>Aspergillus fumigatus - drug effects</topic><topic>Aspergillus fumigatus - growth &amp; development</topic><topic>Biological and medical sciences</topic><topic>blood serum</topic><topic>Cell Line</topic><topic>Cell Membrane</topic><topic>Cell Membrane - metabolism</topic><topic>cell membranes</topic><topic>Chemoprevention</topic><topic>disease control</topic><topic>Epithelial Cells</topic><topic>Epithelial Cells - metabolism</topic><topic>Epithelial Cells - microbiology</topic><topic>fungi</topic><topic>host-pathogen relationships</topic><topic>Humans</topic><topic>itraconazole</topic><topic>Itraconazole - pharmacokinetics</topic><topic>Itraconazole - pharmacology</topic><topic>Lung - cytology</topic><topic>Macrophages</topic><topic>Macrophages - metabolism</topic><topic>Macrophages - microbiology</topic><topic>mammals</topic><topic>Medical sciences</topic><topic>microbial growth</topic><topic>Mycoses</topic><topic>Mycoses - prevention &amp; control</topic><topic>patients</topic><topic>Pharmacology</topic><topic>Pharmacology. Drug treatments</topic><topic>Triazoles</topic><topic>Triazoles - pharmacokinetics</topic><topic>Triazoles - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Campoli, P</creatorcontrib><creatorcontrib>Al Abdallah, Q</creatorcontrib><creatorcontrib>Robitaille, R</creatorcontrib><creatorcontrib>Solis, N. V</creatorcontrib><creatorcontrib>Fielhaber, J. A</creatorcontrib><creatorcontrib>Kristof, A. S</creatorcontrib><creatorcontrib>Laverdiere, M</creatorcontrib><creatorcontrib>Filler, S. G</creatorcontrib><creatorcontrib>Sheppard, D. C</creatorcontrib><collection>AGRIS</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Antimicrobial Agents and Chemotherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Campoli, P</au><au>Al Abdallah, Q</au><au>Robitaille, R</au><au>Solis, N. V</au><au>Fielhaber, J. A</au><au>Kristof, A. S</au><au>Laverdiere, M</au><au>Filler, S. G</au><au>Sheppard, D. C</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Concentration of Antifungal Agents within Host Cell Membranes: a New Paradigm Governing the Efficacy of Prophylaxis</atitle><jtitle>Antimicrobial Agents and Chemotherapy</jtitle><stitle>Antimicrob Agents Chemother</stitle><addtitle>Antimicrob Agents Chemother</addtitle><date>2011-12-01</date><risdate>2011</risdate><volume>55</volume><issue>12</issue><spage>5732</spage><epage>5739</epage><pages>5732-5739</pages><issn>0066-4804</issn><eissn>1098-6596</eissn><coden>AACHAX</coden><abstract>Posaconazole prophylaxis has proven highly effective in preventing invasive fungal infections, despite relatively low serum concentrations. However, high tissue levels of this agent have been reported in treated patients. We therefore hypothesized that the intracellular levels of antifungal agents are an important factor in determining the success of fungal prophylaxis. To examine the effect of host cell-associated antifungals on the growth of medically important molds, we exposed cells to antifungal agents and removed the extracellular drug prior to infection. Epithelial cells loaded with posaconazole and its parent molecule itraconazole, but not other antifungals, were able to inhibit fungal growth for at least 48 h and were protected from damage caused by infection. Cell-associated posaconazole levels were 40- to 50-fold higher than extracellular levels, and the drug was predominantly detected in cellular membranes. Fungistatic levels of posaconazole persisted within epithelial cells for up to 48 h. Therefore, the concentration of posaconazole in mammalian host cell membranes mediates its efficacy in prophylactic regimens and likely explains the observed discrepancy between serum antifungal levels and efficacy.</abstract><cop>Washington, DC</cop><pub>American Society for Microbiology</pub><pmid>21930891</pmid><doi>10.1128/AAC.00637-11</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0066-4804
ispartof Antimicrobial Agents and Chemotherapy, 2011-12, Vol.55 (12), p.5732-5739
issn 0066-4804
1098-6596
language eng
recordid cdi_pubmed_primary_21930891
source MEDLINE; EZB-FREE-00999 freely available EZB journals; PubMed Central
subjects Antibiotics. Antiinfectious agents. Antiparasitic agents
Antifungal Agents
Antifungal Agents - pharmacokinetics
Antifungal Agents - pharmacology
Aspergillus fumigatus
Aspergillus fumigatus - drug effects
Aspergillus fumigatus - growth & development
Biological and medical sciences
blood serum
Cell Line
Cell Membrane
Cell Membrane - metabolism
cell membranes
Chemoprevention
disease control
Epithelial Cells
Epithelial Cells - metabolism
Epithelial Cells - microbiology
fungi
host-pathogen relationships
Humans
itraconazole
Itraconazole - pharmacokinetics
Itraconazole - pharmacology
Lung - cytology
Macrophages
Macrophages - metabolism
Macrophages - microbiology
mammals
Medical sciences
microbial growth
Mycoses
Mycoses - prevention & control
patients
Pharmacology
Pharmacology. Drug treatments
Triazoles
Triazoles - pharmacokinetics
Triazoles - pharmacology
title Concentration of Antifungal Agents within Host Cell Membranes: a New Paradigm Governing the Efficacy of Prophylaxis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T21%3A00%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_fao_a&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Concentration%20of%20Antifungal%20Agents%20within%20Host%20Cell%20Membranes:%20a%20New%20Paradigm%20Governing%20the%20Efficacy%20of%20Prophylaxis&rft.jtitle=Antimicrobial%20Agents%20and%20Chemotherapy&rft.au=Campoli,%20P&rft.date=2011-12-01&rft.volume=55&rft.issue=12&rft.spage=5732&rft.epage=5739&rft.pages=5732-5739&rft.issn=0066-4804&rft.eissn=1098-6596&rft.coden=AACHAX&rft_id=info:doi/10.1128/AAC.00637-11&rft_dat=%3Cpubmed_fao_a%3E21930891%3C/pubmed_fao_a%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/21930891&rfr_iscdi=true